首页 > 最新文献

Journal of neurology and experimental neural science最新文献

英文 中文
Association between Covid-19 Vaccines and Anxiety Covid-19 疫苗与焦虑之间的关系
Pub Date : 2024-01-26 DOI: 10.29011/2577-1442.100051
{"title":"Association between Covid-19 Vaccines and Anxiety","authors":"","doi":"10.29011/2577-1442.100051","DOIUrl":"https://doi.org/10.29011/2577-1442.100051","url":null,"abstract":"","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"9 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139594320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Depressive Symptoms and Perceived Stress in Women Coping with Infertility, Following Mind-Body Interventions 心身干预后不孕妇女抑郁症状和感知压力的变化
Pub Date : 2023-02-24 DOI: 10.29011/2577-1442.100048
{"title":"Changes in Depressive Symptoms and Perceived Stress in Women Coping with Infertility, Following Mind-Body Interventions","authors":"","doi":"10.29011/2577-1442.100048","DOIUrl":"https://doi.org/10.29011/2577-1442.100048","url":null,"abstract":"","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136166345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease. 成人镰状细胞病脑血流动力学和贫血与处理速度的关系
Pub Date : 2023-01-01 DOI: 10.29011/2577-1442.100050
Daniel Sop, Joel L Steinberg, Jennifer Jordan, Taylor Crouch, Yue May Zhang, Wally Smith

Background and purpose: Compared to healthy controls, adult patients with Sickle Cell Disease (SCD) are anemic, and therefore have higher cardiac output and Cerebral Blood Flow (CBF) to maintain brain oxygenation. They also demonstrate comparatively more cognitive deficits due to either overt strokes or silent cerebral ischemia. However, there are few correlative studies between CBF and cognitive deficits, specifically processing speed in SCD. Such studies are important to develop biomarkers of central brain processing and ischemia for diagnosis, prognosis, and evaluating the effectiveness of potential interventions. This pilot cross-sectional study tested the hypotheses that adults with SCD and elevated CBF demonstrate lower central brain processing speed than controls on average and that CBF is inversely correlated with processing speed.

Methods: We conducted a pilot cross-sectional study to assess the relation-ships between CBF, central brain processing speed, and hemoglobin levels in asymptomatic adults with SCD and controls from an urban academic medical center. MRI acquisitions at 3T consisted of 2D phase-contrast quantitative arteriograms (Qflow) of the bilateral internal carotid and vertebral arteries and 3D pseudo-continuous arterial spin labeling (pCASL) of the brain. Participants were patients with SCD (hemoglobin [Hb]SS, [Hb] SBetaThal°, or [Hb]SC) aged 22-52 years of African American descent (N=7) or community controls (Hb AA) (n=3). Processing speed was assessed as an in-direct functional marker of ischemia using a recommended test from the NIH Toolbox for Assessment of Neurological and Behavioral Function, the Pattern Comparison Processing Speed Test. t-tests were used to compare means of CBF, hemoglobin, and cognition between SCD patients and healthy controls. Among SCD patients only multivariate correla-tions were used to evaluate relationships between brain perfusion in specific brain regions vs. processing speed and CBF. The significance level was set at p≤0.05.

Results: Adults with SCD reported higher CBF compared to healthy con-trols (72.15±28.90 vs. 47.23±12.30 ml/min/100g, p=0.04), and lower hemoglobin concentration (8.64±2.33 vs. 13.33±0.58, p=0.001). Heart rate in SCD patients was higher than in controls (86.29±1.37 vs. 74.00±2.10, p=0.04). Patients with SCD demonstrated lower processing speed (96.14±21.04 vs.123±13.74, p=0.02) than controls. Among adult patients with SCD, perfusion in specific regions of the brain showed an inverse relationship with processing speed, as did whole-brain CBF (p=0.0325).

Conclusion: These findings, although from a small sample, lend a degree of validity to the claim that processing speed is slower in people with SCD than in controls and that CBF is significantly higher in SCD patients com-pared to controls. The results also lend credence to the finding that the degree of processing speed deficiencies am

背景和目的:与健康对照相比,成年镰状细胞病(SCD)患者贫血,因此有更高的心输出量和脑血流量(CBF)来维持脑氧合。由于明显的中风或无症状的脑缺血,他们也表现出相对更多的认知缺陷。然而,脑卒中与认知缺陷,特别是认知加工速度之间的相关研究却很少。这些研究对于开发中枢脑加工和缺血的生物标志物,用于诊断、预后和评估潜在干预措施的有效性具有重要意义。本初步横断面研究验证了SCD和CBF升高的成人的中央脑处理速度低于平均对照组的假设,CBF与处理速度呈负相关。方法:我们进行了一项试验性横断面研究,以评估无症状SCD成人和城市学术医疗中心对照组的CBF、中央脑处理速度和血红蛋白水平之间的关系。3T时的MRI采集包括双侧颈内动脉和椎动脉的二维相位对比定量动脉图(Qflow)和大脑的三维伪连续动脉自旋标记(pCASL)。参与者为22-52岁非裔美国人后裔(N=7)或社区对照组(Hb AA)的SCD(血红蛋白[Hb]SS, [Hb] SBetaThal°或[Hb]SC)患者(N= 3)。处理速度被评估为缺血的间接功能标记,使用美国国立卫生研究院神经和行为功能评估工具箱推荐的测试,模式比较处理速度测试。采用t检验比较SCD患者与健康对照者的CBF、血红蛋白和认知水平。在SCD患者中,仅使用多变量相关性来评估特定脑区域的脑灌注与处理速度和CBF之间的关系。显著性水平设为p≤0.05。结果:SCD成人CBF高于健康对照组(72.15±28.90 vs. 47.23±12.30 ml/min/100g, p=0.04),血红蛋白浓度较低(8.64±2.33 vs. 13.33±0.58,p=0.001)。SCD患者心率高于对照组(86.29±1.37 vs. 74.00±2.10,p=0.04)。SCD患者的处理速度(96.14±21.04 vs.123±13.74,p=0.02)低于对照组。在成年SCD患者中,大脑特定区域的灌注与处理速度呈反比关系,全脑CBF也是如此(p=0.0325)。结论:这些发现,虽然来自一个小样本,但在一定程度上证明了SCD患者的处理速度比对照组慢,而SCD患者的CBF明显高于对照组。研究结果还证实了下述发现:成人SCD患者的处理速度缺陷程度与CBF升高程度相关,而CBF升高程度与SCD相关的贫血程度相对应。
{"title":"Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease.","authors":"Daniel Sop,&nbsp;Joel L Steinberg,&nbsp;Jennifer Jordan,&nbsp;Taylor Crouch,&nbsp;Yue May Zhang,&nbsp;Wally Smith","doi":"10.29011/2577-1442.100050","DOIUrl":"https://doi.org/10.29011/2577-1442.100050","url":null,"abstract":"<p><strong>Background and purpose: </strong>Compared to healthy controls, adult patients with Sickle Cell Disease (SCD) are anemic, and therefore have higher cardiac output and Cerebral Blood Flow (CBF) to maintain brain oxygenation. They also demonstrate comparatively more cognitive deficits due to either overt strokes or silent cerebral ischemia. However, there are few correlative studies between CBF and cognitive deficits, specifically processing speed in SCD. Such studies are important to develop biomarkers of central brain processing and ischemia for diagnosis, prognosis, and evaluating the effectiveness of potential interventions. This pilot cross-sectional study tested the hypotheses that adults with SCD and elevated CBF demonstrate lower central brain processing speed than controls on average and that CBF is inversely correlated with processing speed.</p><p><strong>Methods: </strong>We conducted a pilot cross-sectional study to assess the relation-ships between CBF, central brain processing speed, and hemoglobin levels in asymptomatic adults with SCD and controls from an urban academic medical center. MRI acquisitions at 3T consisted of 2D phase-contrast quantitative arteriograms (Qflow) of the bilateral internal carotid and vertebral arteries and 3D pseudo-continuous arterial spin labeling (pCASL) of the brain. Participants were patients with SCD (hemoglobin [Hb]SS, [Hb] SBetaThal°, or [Hb]SC) aged 22-52 years of African American descent (N=7) or community controls (Hb AA) (n=3). Processing speed was assessed as an in-direct functional marker of ischemia using a recommended test from the NIH Toolbox for Assessment of Neurological and Behavioral Function, the Pattern Comparison Processing Speed Test. t-tests were used to compare means of CBF, hemoglobin, and cognition between SCD patients and healthy controls. Among SCD patients only multivariate correla-tions were used to evaluate relationships between brain perfusion in specific brain regions vs. processing speed and CBF. The significance level was set at p≤0.05.</p><p><strong>Results: </strong>Adults with SCD reported higher CBF compared to healthy con-trols (72.15±28.90 vs. 47.23±12.30 ml/min/100g, p=0.04), and lower hemoglobin concentration (8.64±2.33 vs. 13.33±0.58, p=0.001). Heart rate in SCD patients was higher than in controls (86.29±1.37 vs. 74.00±2.10, p=0.04). Patients with SCD demonstrated lower processing speed (96.14±21.04 vs.123±13.74, p=0.02) than controls. Among adult patients with SCD, perfusion in specific regions of the brain showed an inverse relationship with processing speed, as did whole-brain CBF (p=0.0325).</p><p><strong>Conclusion: </strong>These findings, although from a small sample, lend a degree of validity to the claim that processing speed is slower in people with SCD than in controls and that CBF is significantly higher in SCD patients com-pared to controls. The results also lend credence to the finding that the degree of processing speed deficiencies am","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464389/pdf/nihms-1922726.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain® Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study 膳食补充高剂量Alfoscorate胆碱(Cerebrain®Forte)对轻度神经认知障碍(Mind)患者认知功能的影响:一项初步研究
Pub Date : 2022-05-09 DOI: 10.29011/2577-1442.100046
E. Garofalo, M. Sannino, A. Iavarone, Bruno, Ronga
Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study. J Abstract Introduction and aim of the study: Normal and pathological aging have been related to deficits of several neurotransmitters able to account for cognitive, emotional and behavioral disorders associated with mild cognitive decline or overt dementia. Among the neurotransmitter deficits involved in cognitive disorders, with particular reference to those underlying memory and attentional functions, the cholinergic one is certainly the main one [1]. This justified the treatment of these disorders with drugs and supplements capable of enhancing cholinergic transmission by inhibiting the degradation of acetylcholine (acetylcholinesterase inhibitors) or by increasing the production of the neurotransmitter through the exogenous supply of precursors [2,3]. Choline Alfoscerate is at the forefront of these supplements. The effect of the supplements is dose-dependent, and it is therefore likely that a high-dose formulation is associated with effects on cognition of a higher entity than that with medium or medium-low dosages. Aim of this pilot study is to evaluate the effects of dietary supplementation
膳食补充高剂量胆碱alfoscate (Cerebrain Forte)对轻度神经认知障碍(Mind)患者认知功能的影响:一项初步研究【摘要】研究简介和目的:正常和病理性衰老与几种神经递质缺陷有关,这些神经递质能够解释与轻度认知能力下降或显性痴呆相关的认知、情绪和行为障碍。在与认知障碍有关的神经递质缺陷中,特别是与潜在的记忆和注意力功能有关的神经递质缺陷,胆碱能缺陷无疑是主要的。这证明了使用能够通过抑制乙酰胆碱降解(乙酰胆碱酯酶抑制剂)或通过外源性前体供应增加神经递质产生来增强胆碱能传递的药物和补充剂来治疗这些疾病是合理的[2,3]。高脂胆碱是这些补充剂的前沿。补充剂的效果是剂量依赖性的,因此,与中剂量或中低剂量制剂相比,高剂量制剂可能与对更高实体的认知作用有关。本初步研究的目的是评估膳食补充剂的效果
{"title":"Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain® Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study","authors":"E. Garofalo, M. Sannino, A. Iavarone, Bruno, Ronga","doi":"10.29011/2577-1442.100046","DOIUrl":"https://doi.org/10.29011/2577-1442.100046","url":null,"abstract":"Effects of Dietary Supplementation with High-Dose Choline Alfoscerate (Cerebrain Forte) on Cognitive Functioning in Patients with Minor Neurocognitive Disorder (Mind): A Pilot Study. J Abstract Introduction and aim of the study: Normal and pathological aging have been related to deficits of several neurotransmitters able to account for cognitive, emotional and behavioral disorders associated with mild cognitive decline or overt dementia. Among the neurotransmitter deficits involved in cognitive disorders, with particular reference to those underlying memory and attentional functions, the cholinergic one is certainly the main one [1]. This justified the treatment of these disorders with drugs and supplements capable of enhancing cholinergic transmission by inhibiting the degradation of acetylcholine (acetylcholinesterase inhibitors) or by increasing the production of the neurotransmitter through the exogenous supply of precursors [2,3]. Choline Alfoscerate is at the forefront of these supplements. The effect of the supplements is dose-dependent, and it is therefore likely that a high-dose formulation is associated with effects on cognition of a higher entity than that with medium or medium-low dosages. Aim of this pilot study is to evaluate the effects of dietary supplementation","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41577557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study 低频高强度脉冲电磁场(抗磁疗法)治疗罕见病疗效的病例系列初步研究
Pub Date : 2022-02-09 DOI: 10.29011/2577-1442.100045
Felipe Torres Obando, P. Romeo, D. Vergara, Fede G Di, Pardo, Adriana Soto
Rare and orphan diseases are a group of multiorgan disabilities that limit the life quality in young and adult patients, affecting the socio-economic burden for the families and the community. Despite the continuous attempts in research, no standardized and effective therapies are nowadays available. Orthosis supports and rehabilitation remain the unique possibilities to alleviate these challenging conditions. Among the emerging therapeutic odds, Pulsed Electromagnetic Fields (PEMFs) express anti-inflammatory and regenerative effects on musculoskeletal and parenchymal tissues. They have also shown intriguing properties to stimulate the central and peripheral nervous system either as Transcranial Magnetic Stimulation (TMS) and Low Frequency High-Intensity -Pulsed electromagnetic Field (LF-HI-PEMFs) or Diamagnetic Therapy (Diamagneto-therapy). This last modulates brain plasticity and is effective in pain, reducing muscles contractures and tissue oedema. Our experience refers to the use of Diamagnetic Therapy to rare and orphan diseases and reports promising functional and behavioural results, opening the possibility of therapeutic applications integrated with conventional rehabilitative methods. Journal of Neurology and Experimental Neural Science Obando FT, et al. J Neurol Exp Neural Sci 4: 145. www.doi.org/10.29011/2577-1442.100045 www.gavinpublishers.com Introduction Rare and orphan diseases are a group of pathologies that affect, by definition, small numbers of patients. The classification criteria are different in the various countries as there is no unified categorization globally accepted. According to the United States Rare Diseases Act (2002), a rare disease is a condition that affects about 1: 1500 person while the European Commission defines a rare disease as any disease that affects less than 1: 2000 people and some definitions rely on the existence of proper treatments [1]. Currently, despite their low prevalence, almost 8000 existing rare diseases are esteemed to affect about 350 million patients, with a worldwide impact on healthcare and the socio-economic systems in terms of direct and indirect costs. Recent progress in molecular biology, next-generation sequencing-based technologies, and genetics have enhanced the therapeutic choices: small-molecule drugs, protein-based therapeutics, antisense oligonucleotides, small interfering RNAs, gene and cell therapies [2] aim to trigger reparative molecular Citation: Obando FT, Romeo P, Vergara D, di Pardo F, Soto A (2022) The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study. J Neurol Exp Neural Sci 4: 145. DOI: 10.29011/2577-1442.100045 2 Volume 4; Issue 01 mechanisms. Nevertheless, there is still a lack of appropriate diagnostic tools and treatments that need more specific knowledge [3]. Thus, despite the growing interest in this field, the high costs related to the rarity of the d
罕见病和孤儿病是一组多器官残疾,限制了青年和成年患者的生活质量,影响了家庭和社区的社会经济负担。尽管研究不断尝试,但目前尚无标准化和有效的治疗方法。矫形器支持和康复仍然是缓解这些具有挑战性的条件的独特可能性。在新兴的治疗方法中,脉冲电磁场(pemf)对肌肉骨骼和实质组织具有抗炎和再生作用。它们还显示出刺激中枢和周围神经系统的有趣特性,如经颅磁刺激(TMS)和低频高强度脉冲电磁场(lf - hi - pemf)或抗磁疗法(Diamagneto-therapy)。这最后调节大脑的可塑性,是有效的疼痛,减少肌肉挛缩和组织水肿。我们的经验是使用抗磁疗法治疗罕见病和孤儿病,并报告了有希望的功能和行为结果,开辟了与传统康复方法相结合的治疗应用的可能性。《神经学与实验神经科学杂志》。中国生物医学工程学报(英文版),41(4):444 - 444。www.doi.org/10.29011/2577-1442.100045 www.gavinpublishers.com介绍罕见病和孤儿病是一组病理,根据定义,影响少数患者。由于没有全球公认的统一分类,各国的分类标准各不相同。根据美国《罕见病法》(2002年),罕见病是影响约1:15 500人的病症,而欧洲委员会将罕见病定义为影响少于1:2 000人的任何疾病,一些定义依赖于是否存在适当的治疗方法。目前,尽管发病率很低,但据估计,现有的近8000种罕见病影响了约3.5亿患者,在直接和间接成本方面对全球卫生保健和社会经济系统产生了影响。分子生物学、基于新一代测序技术和遗传学的最新进展增加了治疗选择:小分子药物、基于蛋白质的疗法、反义寡核苷酸、小干扰rna、基因和细胞疗法等,旨在触发修复分子。欧本多,王晓明,王晓明,等(2022)低频高强度脉冲电磁场(抗磁疗法)治疗罕见病的临床研究。中国生物医学工程学报(英文版),41(4):444 - 444。DOI: 10.29011/2577-1442.100045 2卷4;文档版本01机制。然而,仍然缺乏适当的诊断工具和治疗方法,需要更具体的知识。因此,尽管人们对这一领域的兴趣日益浓厚,但由于这些疾病的罕见性和其不明确的发病机制,其高昂的费用延缓了在特定治疗费用方面的进展。鉴于神经系统的频繁参与,最近的治疗尝试之一是生物物理刺激,其目标是改变特定大脑或外周区域的兴奋性和可塑性。重复经颅磁刺激(rTMS)是一种对大脑和神经系统进行电磁刺激的无创无痛技术。针对疼痛、运动障碍、中风、肌萎缩侧索硬化症、多发性硬化症、癫痫和其他疾病的实验证据,制定了适当的rTMS治疗指南。就其本身而言,脉冲电磁场(pemf)诱导的电磁刺激保留了世界公认的生物效应,在治疗疼痛和炎症以及再生医学,药物输送和免疫治疗方面都是有效的。pemf也已成功应用于肌肉骨骼疾病[6],以调节各种神经递质的活性和大脑皮层的可塑性[7,8]。由于常规治疗的反复无效,基于以往的经验,我们采用了一种新颖的PEMF技术来治疗一系列13例患有与罕见疾病相关的神经运动和行为障碍的患者。我们使用了一种基于低频高强度脉冲电磁场(LFHIPEMFs)的治疗方法,名为抗磁疗法(Diamagnetotherapy),取得了积极的效果。方法2019年5月至2021年4月,在哥伦比亚波哥大<e:1>细胞再生医疗组织,对13例年龄不同、患有不同神经肌肉罕见疾病的患者进行抗磁治疗。 其中肌营养不良2例,神经轴突营养不良1例,痉挛性脑瘫6例,出血性中风1例,左局灶性癫痫1例,肌张力障碍28例,Glass综合征1例,胼胝体发育不良1例,小脑桥发育不全1例,背腰椎发育不良1例。除了标准护理外,他们还使用了CTU Mega 20®Plus抗磁泵机(Periso SA - PazzalloSwitzerland)进行抗磁治疗的个性化治疗。根据疾病的症状和特征,卫生人员使用了不同的治疗方案。该技术提供高强度-低频电磁场(2.2 t - <50 Hz),并提供宽范围的磁场振幅和可变电磁频率,能够匹配身体组织的电磁特性,在细胞水平上刺激它们[8]。治疗区域的选择取决于疾病的发病机制。在中枢神经系统(CNS)的病理中,直接经颅刺激已被应用,如果涉及周围神经系统和肌肉(PNS),我们治疗有关的周围区域。与使用PEMF的传统技术一样,这些治疗的主要目标是刺激细胞的代谢活性。此外,CTU Mega 20 Plus机器提供了移动抗磁性物质的可能性,如水、离子和细胞外基质(ECM)的蛋白质,促进细胞水平的跨膜流动。此外,由于有可能根据生物组织的需要,有选择地改变电磁频率和磁场的振幅,激活肌肉装置,即慢速和快速神经纤维的电传导。表1总结了根据诊断、治疗方案和治疗范围、治疗次数为每位患者提供的治疗的主要特征。引用本文:Obando FT, Romeo P, Vergara D, di Pardo F, Soto A(2022)低频高强度脉冲电磁场(抗磁疗法)治疗罕见病的效果:病例系列初步研究。中国生物医学工程学报(英文版),41(4):444 - 444。DOI: 10.29011/2577-1442.100045 3 Volume 4;第01期患者诊断治疗区域抗磁治疗次数患者1肢带肌营养不良臀腰椎疼痛控制慢神经纤维刺激
{"title":"The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study","authors":"Felipe Torres Obando, P. Romeo, D. Vergara, Fede G Di, Pardo, Adriana Soto","doi":"10.29011/2577-1442.100045","DOIUrl":"https://doi.org/10.29011/2577-1442.100045","url":null,"abstract":"Rare and orphan diseases are a group of multiorgan disabilities that limit the life quality in young and adult patients, affecting the socio-economic burden for the families and the community. Despite the continuous attempts in research, no standardized and effective therapies are nowadays available. Orthosis supports and rehabilitation remain the unique possibilities to alleviate these challenging conditions. Among the emerging therapeutic odds, Pulsed Electromagnetic Fields (PEMFs) express anti-inflammatory and regenerative effects on musculoskeletal and parenchymal tissues. They have also shown intriguing properties to stimulate the central and peripheral nervous system either as Transcranial Magnetic Stimulation (TMS) and Low Frequency High-Intensity -Pulsed electromagnetic Field (LF-HI-PEMFs) or Diamagnetic Therapy (Diamagneto-therapy). This last modulates brain plasticity and is effective in pain, reducing muscles contractures and tissue oedema. Our experience refers to the use of Diamagnetic Therapy to rare and orphan diseases and reports promising functional and behavioural results, opening the possibility of therapeutic applications integrated with conventional rehabilitative methods. Journal of Neurology and Experimental Neural Science Obando FT, et al. J Neurol Exp Neural Sci 4: 145. www.doi.org/10.29011/2577-1442.100045 www.gavinpublishers.com Introduction Rare and orphan diseases are a group of pathologies that affect, by definition, small numbers of patients. The classification criteria are different in the various countries as there is no unified categorization globally accepted. According to the United States Rare Diseases Act (2002), a rare disease is a condition that affects about 1: 1500 person while the European Commission defines a rare disease as any disease that affects less than 1: 2000 people and some definitions rely on the existence of proper treatments [1]. Currently, despite their low prevalence, almost 8000 existing rare diseases are esteemed to affect about 350 million patients, with a worldwide impact on healthcare and the socio-economic systems in terms of direct and indirect costs. Recent progress in molecular biology, next-generation sequencing-based technologies, and genetics have enhanced the therapeutic choices: small-molecule drugs, protein-based therapeutics, antisense oligonucleotides, small interfering RNAs, gene and cell therapies [2] aim to trigger reparative molecular Citation: Obando FT, Romeo P, Vergara D, di Pardo F, Soto A (2022) The Effects of Low-Frequency High-Intensity Pulsed Electromagnetic Fields (Diamagnetic Therapy) in the Treatment of Rare Diseases: A Case Series Preliminary Study. J Neurol Exp Neural Sci 4: 145. DOI: 10.29011/2577-1442.100045 2 Volume 4; Issue 01 mechanisms. Nevertheless, there is still a lack of appropriate diagnostic tools and treatments that need more specific knowledge [3]. Thus, despite the growing interest in this field, the high costs related to the rarity of the d","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48374692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Energy Alterations and Chakras Energy Deficiencies in the Pathophysiology of Bell’s Palsy 贝尔氏麻痹病理生理学中的能量改变和脉轮能量不足
Pub Date : 2020-01-01 DOI: 10.29011/2577-1442.000140
H. Ling
Introduction: Bell’s palsy (BP) is a loss of facial movement due to nerve damage. In traditional Chinese medicine (TCM), the physiopathology of BP is external Wind-Cold attacking the channels of the face. Purpose: To demonstrate which are the energy alterations on the chakras energy centers on patients with Bell’s palsy and the results of the treatment using TCM tools. Methods: Three case reports of patients with Bell’s palsy. All with history of developing Bell’s palsy after exposure to Cold and Wind. They received measurement of the chakras, and in all the cases, they had no energy in all seven chakras. The treatment was recommendation to avoid exposure to Cold and Wind, Chinese dietary counselling, acupuncture, and treatment for the chakras with homeopathy medication according to the theory of the author entitled Constitutional Homeopathy of the Five Elements based on Traditional Chinese Medicine and crystal-based medications. Results: All patients presented improvement of the Bell’s palsy, restoring nerve function, besides improving the ability of the patients to close their eyes and improvement of the well-being, self-esteem and emotional state. Conclusion: In this study, it was concluded that patients with Bell’s palsy have an energy deficiency on the chakras centers that make them more prone to invasion of Wind and Cold, due to weakened energy, leading, in this case, to the formation of Bell’s palsy. In this study, TCM tools were used for restoring the function of the facial nerves and muscles and rebalancing all the energy of the patients (Yin, Yang, Qi and Blood and chakras energy). The use of high-concentrated medication, such as corticosteroids, normally used in Western medicine treatment, may harm the vital energy of the patients even more, worsening or maintaining the condition of energy imbalance, and therefore, Bell’s palsy. Biography: Huang Wei Ling, born in Taiwan, raised in Brazil since the age of one, graduated in medicine in Brazil, specializing in infectious and parasitic diseases, General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture and Pain Management Practitioner. Since 2007, she has been disseminating the knowledge of Oriental medicine, especially traditional Chinese medicine, in various places around the world, in the treatment of the various pathologies of the human body. Owner of Medical Acupuncture and Pain Management Clinic. Speaker Publications: 1. “The Importance of Correcting Chakras Energy Centers Alterations to Prevent Pacemaker Indication”. 2. “Energy Alterations Leading to Dyspnea in Patients with Mitral Valve Stenosis”. 3. “The Importance of Correcting Energy Imbalances in the Prevention and Treatment of Myocardial Infarction”. International Conference on Neurologists; WebinarNovember 27, 2020.
贝尔氏麻痹(BP)是由于神经损伤导致的面部运动丧失。中医认为BP的生理病理是外源性风寒侵袭面部经络。目的:探讨贝尔麻痹患者脉轮能量中心的能量变化及中医治疗的效果。方法:对3例贝尔麻痹患者进行回顾性分析。都有暴露在寒风中患上贝尔氏麻痹的病史。他们接受了脉轮的测量,在所有情况下,他们在所有七个脉轮中都没有能量。治疗建议避免暴露在寒冷和风中,中医饮食咨询,针灸,以及根据作者的理论使用顺势疗法治疗脉轮,该理论题为“基于传统中医和水晶药物的五行体质顺势疗法”。结果:所有患者贝尔麻痹症状均有改善,神经功能恢复,闭眼能力提高,幸福感、自尊和情绪状态均有改善。结论:在这项研究中,我们得出结论,贝尔氏麻痹患者在脉轮中心有能量不足,使他们更容易受到风寒的侵袭,由于能量减弱,导致贝尔氏麻痹的形成。在这项研究中,中医工具被用于恢复面部神经和肌肉的功能,并重新平衡患者的所有能量(阴、阳、气、血和脉轮能量)。使用高浓度药物,如西医治疗中常用的皮质类固醇,可能会对患者的元气造成更大的伤害,使能量失衡的状况恶化或维持,从而导致贝尔麻痹。简介:黄卫玲,出生于台湾,1岁起在巴西长大,毕业于巴西医学专业,专攻传染病和寄生虫病,全科医生,肠外医学营养治疗师,针灸和疼痛管理医生。自2007年以来,她一直在世界各地传播东方医学,特别是中医的知识,治疗人体的各种疾病。医学针灸和疼痛管理诊所的老板。演讲者出版物:1;“纠正脉轮能量中心改变以防止起搏器指示的重要性”。2. 二尖瓣狭窄患者的能量改变导致呼吸困难。3.“纠正能量失衡在防治心肌梗死中的重要性”。国际神经科医师会议;2020年11月27日。
{"title":"Energy Alterations and Chakras Energy Deficiencies in the Pathophysiology of Bell’s Palsy","authors":"H. Ling","doi":"10.29011/2577-1442.000140","DOIUrl":"https://doi.org/10.29011/2577-1442.000140","url":null,"abstract":"Introduction: Bell’s palsy (BP) is a loss of facial movement due to nerve damage. In traditional Chinese medicine (TCM), the physiopathology of BP is external Wind-Cold attacking the channels of the face. Purpose: To demonstrate which are the energy alterations on the chakras energy centers on patients with Bell’s palsy and the results of the treatment using TCM tools. Methods: Three case reports of patients with Bell’s palsy. All with history of developing Bell’s palsy after exposure to Cold and Wind. They received measurement of the chakras, and in all the cases, they had no energy in all seven chakras. The treatment was recommendation to avoid exposure to Cold and Wind, Chinese dietary counselling, acupuncture, and treatment for the chakras with homeopathy medication according to the theory of the author entitled Constitutional Homeopathy of the Five Elements based on Traditional Chinese Medicine and crystal-based medications. Results: All patients presented improvement of the Bell’s palsy, restoring nerve function, besides improving the ability of the patients to close their eyes and improvement of the well-being, self-esteem and emotional state. Conclusion: In this study, it was concluded that patients with Bell’s palsy have an energy deficiency on the chakras centers that make them more prone to invasion of Wind and Cold, due to weakened energy, leading, in this case, to the formation of Bell’s palsy. In this study, TCM tools were used for restoring the function of the facial nerves and muscles and rebalancing all the energy of the patients (Yin, Yang, Qi and Blood and chakras energy). The use of high-concentrated medication, such as corticosteroids, normally used in Western medicine treatment, may harm the vital energy of the patients even more, worsening or maintaining the condition of energy imbalance, and therefore, Bell’s palsy. Biography: Huang Wei Ling, born in Taiwan, raised in Brazil since the age of one, graduated in medicine in Brazil, specializing in infectious and parasitic diseases, General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture and Pain Management Practitioner. Since 2007, she has been disseminating the knowledge of Oriental medicine, especially traditional Chinese medicine, in various places around the world, in the treatment of the various pathologies of the human body. Owner of Medical Acupuncture and Pain Management Clinic. Speaker Publications: 1. “The Importance of Correcting Chakras Energy Centers Alterations to Prevent Pacemaker Indication”. 2. “Energy Alterations Leading to Dyspnea in Patients with Mitral Valve Stenosis”. 3. “The Importance of Correcting Energy Imbalances in the Prevention and Treatment of Myocardial Infarction”. International Conference on Neurologists; WebinarNovember 27, 2020.","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69472216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Energy Disturbances in Panic Syndrome and How Can We Treat it in Adolescence? 青少年惊恐综合征中的能量紊乱及如何治疗?
Pub Date : 2020-01-01 DOI: 10.29011/2577-1442.000139
{"title":"Energy Disturbances in Panic Syndrome and How Can We Treat it in Adolescence?","authors":"","doi":"10.29011/2577-1442.000139","DOIUrl":"https://doi.org/10.29011/2577-1442.000139","url":null,"abstract":"","PeriodicalId":73859,"journal":{"name":"Journal of neurology and experimental neural science","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69471449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Journal of neurology and experimental neural science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1